GU Cast | Urology Podcast

It's pretty shocking how many prostate cancers went missing during COVID, especially in Melbourne which experienced the most prolonged lockdown in the world. The data is still being cleaned but it is estimated that up to 3000 men who would have been expected to be diagnosed with prostate cancer over the past 2.5 years, have not yet been diagnosed. It is prostate cancer awareness month in Aust...

It wasn't that long ago that we would have scoffed at the idea of using radiation therapy to treat primary kidney cancer. Not any more!! We are joined by two top experts in kidney cancer, and leaders of ongoing research in this field, to discuss the expanding role for radiation therapy in managing primary renal cancer. Dr Rana McKay, GU Medical Oncologist at the University of California, San...

International speaker tours are back! And this week we had two fantastic GU oncology experts visiting Australia to do a lecture tour on hot topics in metastatic prostate cancer.  So of course we invited them to attend our multidisciplinary team meeting at Peter MacCallum Cancer Centre, then pop upstairs to teh Gu Cast studio. Dr Tian Zhang from UT Southwestern in Dallas, and Dr Rahul Aggarwal from...

It's been two and half years since we posted our first GU Cast and it's been fun! We are so grateful to all our listeners and viewers for supporting us, sending us great comments, and getting involved in the conversation. GU Oncology is such a fast-moving world, and we have really enjoyed posting content to keep ourselves and our audiences up to date. We also have some exciting plans to...

GU Cast is pleased to cross-post another of these excellent ProsTIC PSMA theranostics webinars in collaboration with the Priotate Cancer Foundation's Global Knowledge Exchange programs. This webinar focuses on the new era of PSMA theranostics post-FDA approval. This webinar is co-hosted by Professor Michael Hofman, Nuclear Medicine Physician and Director of ProsTIC at Peter MacCallum Cancer C...

Part 2 of our #EAU22 highlights from Amsterdam features chats with EAU Guidelines Chair Professor Maria Ribal, the inimitable Associate Professor David Bouchier-Hayes, and a roving report from Dr Sophie Rintoul-Hoad as she sails around Amsterdam's canals. Plus some live reporting from the GU Cast reception at the Hoopman Pub in Amsterdam with Dr Alastair Lamb, Dr Marcus Cumberbatch, Dr Ben Ch...

Declan and Renu bring you the first of their two part #EAU22 conference highlights from Amsterdam. How great to have the EAU back in person! We catch up with lots of old friends and bring you top scientific highlights. Guests on this episode include Jim Catto, Peter Black, Tim O'Brien, Eva Comperat, plus some fun on EAU TV with Chris Sweeney and Alberto Briganti. Also on YouTube here  Our web...

USANZ ASM is back! Yey! The Urological Society of Australia & New Zealand ASM was one of the first victims of the pandemic in 2020, and has finally returned, albeit delayed from its usual Feb/March slot. We caught up with a bunch of local and international delegates on the Gold Coast to talk about their scientific and social highlights. Enjoy! Also cross posted on Youtube , well worth a watch!...

Wow did this paper cause a fuss this week!! The ENACT trial was published online in JAMA Oncology last weekend and provoked a huge outcry on social media. Many people were  genuinely shocked at the study design, the conclusions, even the title of the study. We've linked to the paper below, but in summary, this prospective multi centre study enrolled patients with with low-risk or favourable i...

GU Cast returns to one of our favourite topics - PSMA imaging and theranostics! We chat with Nuclear Medicine Physician Professor Michael Hofman, and GU Medical Oncologist, Associate Professor Arun Azad, about some PSMA highlights at the recent ASCO Annual Meeting. Michael presented the eagerly anticipated overall survival data from the TheraP trial in the oral abstract session, and discusses the...

Part 2 of Declan's visit to the Martini-Klinik in Hamburg. Today he chats with Professor Derya Tilki, Urologist and Clinician Researcher, about their ongoing  research activities, including the huge database of radical prostatectomy outcomes which now includes a staggering 35,000 patients. Plus a fantastic trip to the operating room with Professor Tobias Maurer to perform PSMA-guided salvage...

Declan Murphy continues his sabbatical adventures in Europe by spending a few days at the famous Martini-Klinik in Hamburg. The Martini-Klinik is the world's largest radical prostatectomy centre, and is preparing to move to a new building to increase their capacity even more. In this first part of a two-part podcast/videocast, Declan chats with Chief of Urology Professor Markus Graefen, and s...

In his third and final podcast from Lugano, Declan chats with Dr Axel Merseberger (Lubeck), Dr Jochen Walk (Marseille), Ms Jane Fisher (Melbourne), and Dr Chris Sweeney (Boston/Adelaide). Plus listen out for fantastic father and son act, Professor Joe and Oisin O'Sullivan, who played for the crowds outside the Villa Cian.  Silke Gillessen and Aurelius Omlin were also pleased to announce the d...

Declan continues his three part podcast from the Advanced Prostate Cancer Consensus Conference (APCCC) 2022. Imaging played a very dominant (and disruptive) role at APCCC 2022, especially PSMA PET/CT with lots of “train has left the station analogies” and a healthy amount of panellists wanting to stay on the platform!  Today Declan speaks with four imaging experts to hear their thoughts. Nuclear M...

Declan Murphy stops off at the world-famous Netherlands Cancer Institute (NKI) in Amsterdam for a couple of days to visit his old friend, Professor Henk van der Poel. Henk is Consultant Urologist and Chief of Urology at the NKI, and leads a fantastic team with world-renowned expertise in GU oncology.  Declan spends a day in the operating room to watch Henk perform robotic radical prostatectomy and...

To celebrate the return of the world’s premiere prostate cancer meeting, GU Cast is very pleased to bring you the first of three special editions from the Advanced Prostate Cancer Consensus Conference 2022. GU Cast co-host Professor Declan Murphy joined other panellists and delegates in beautiful Lugano, and recorded interviews with many other speakers and attendees, and captured some fantastic fo...

Another GU Cast special from the ProsTIC Preceptorship in Melbourne. Today Dr Renu Eapen welcomes back guest co-host Associate Professor Arun Azad, Medical Oncologist at Peter MacCallum Cancer Centre, to discuss some fantastic translational work going on in his Centre based on our Lutetium PSMA experience. We welcome three great guests to talk about their work. Dr Luc Furic is Head of Translationa...

GU Cast moved on-site this week to the ProsTIC Preceptorship in Melbourne, a state-of-the-art meeting focusing on PSMA Theransotics, led by the PCF-funded ProsTIC Centre of Excellence at Peter MacCallum Cancer Centre. What a great meeting! In-person and virtual with on-demand available for two years (links below). We invited international guest Dr Tom Hope, Nuclear Medicine Physician and Radiologi...

Today Declan and Renu chat with two young doctors who have spent the past few weeks on the Poland-Ukraine border, helping with the refugee crisis triggered by Russia's invasion of Ukraine. Just amazing stories of desperation and tragedy, with some inspiring tales of resilience and generosity. Dr Laura Bukavina is a Urology Fellow at Fox Chase Cancer Centre in Philadelphia, and Dr Alberto Cast...

Well the data are clear, says eminent biostatistician and research methodologist, Dr Andrew Vickers of Memorial-Sloan Kettering Cancer Centre in New York. In some well constructed recent articles, Andrew has really made us think again about the impact of  moving to MRI-directed triage and targeted biopsies, instead of "blind" systematic biopsies. Could it be that this strategy actually l...

2022 finally sees some return to normality in the world of GU conferences. Hooray! Today we chat with the leaders of two of our absolute favourite meetings - the European Association of Urology (EAU) Annual Meeting, and the Advanced Prostate Cancer Consensus Conference (APCCC). We are joined from Germany by Chair of the EAU Scientific Committee Professor Peter Albers, and from Switzerland by Presi...

This week saw the opening of another multi-centre randomised trial of PSMA PET/CT in Australia. And it's a cracker! PRIMARY 2 follows on from the success of the PRIMARY trial published in European Urology recently (see links below). It is aimed at men with some clinical suspicion of prostate cancer, but no definite lesion on MRI (PIRADS 2/3). Is it ok to just to monitor these men (a la PRECIS...

GU Cast is back after our summer break in Melbourne, with a cracking episode focussing on pelvic lymph node dissection in prostate cancer. Pelvic lymph node dissection (PLND) is a perennially contentious topic in urology, and we were delighted today to welcome Dr Karim Touijer, Attending Surgeon at Memorial Sloan Kettering in New York, to discuss the randomised controlled trial which he and his co...

Of all the public health messages out there about the merits of getting vaccinated against COVID, there is one that stands out from the crowd. It's the #SaveTheFutureBoners campaign, warning men that COVID may lead to a significant increased risk of erectile dysfunction!  The campaign is led by a  group of urologists in the US called Urologists United for Vaccination Education , and they have...

In the past few weeks we noticed some strangeness appearing in the PSA reports from one of our major pathology providers here in Australia. Dorevitch Pathology had started reporting PSA levels using BOTH the Siemens Atellica assay, AND the Abbott Alinity assay on the same blood sample. So patients were turning up with two PSA results for the same sample - and were these the same?? Afraid not! Some...